Skip to main content
Caplight Logo









Cellarity

Cellarity

Private
Somerville, MassachusettsHealthcare & Life Scienceshttps://cellarity.com/

Last Round

Series C

Oct 4, 2022

Est. Valuation

$621M

Total Funding Raised

$274M

Company Overview

Cellarity is a biotechnology company that develops oral therapeutics by utilizing an artificial intelligence platform to study and correct whole cell-state dysfunction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoveryAI drug discoverycell state modulationin silico drug discoverytoxicogenomicsdrug safety predictionsingle-cell analysisAI biotechtherapeutic developmentcomputational biologypredictive toxicologymachine learning biologybiotech platformdrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellarity Comparables

Compare Cellarity with similar companies based on industry and business-model similarity.

Cellarity comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Valo Health
84%
Iambic Therapeutics
82%
Insitro
81%

Cellarity Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 4, 2022
Series BFeb 25, 2021
Series ADec 10, 2019

Cellarity Investors

Notable investors and investment history

Cellarity investors
InvestorRounds
Pictet GroupSeries B
JIMCOSeries B
Flagship PioneeringSeries C, Series B, Series A
BlackRockSeries B
Hanwha ImpactSeries C
The Baupost GroupSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 4, 2025

    Two oral presentations at the 67th ASH Annual Meeting.

  • May 12, 2025

    Ted Myles appointed as the new Chief Executive Officer.

Cellarity Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellarity Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellarity's valuation, stock price, and market status.

Firmographic Details

HeadquartersSomerville, Massachusetts
Employee Range68
Year Founded2017
Last FundingOct 4, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?